Related Experiment Videos
Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA
F Forozan1, E H Mahlamäki, O Monni
1Cancer Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, Maryland 20892-4470, USA.
Cancer Research
|September 2, 2000
Summary
Comparative genomic hybridization (CGH) of breast cancer cell lines reveals genetic alterations mirroring uncultured tumors. These DNA copy number profiles aid in identifying key genes involved in breast cancer development and progression.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Breast cancer cell lines are crucial models for gene discovery and functional analysis.
- Understanding genetic alterations in cell lines is key to their relevance in modeling human tumors.
Purpose of the Study:
- To characterize recurrent genetic alterations in 38 breast cancer cell lines using CGH.
- To compare these alterations with those found in uncultured breast tumors.
- To identify potential new genes involved in breast cancer through copy number analysis.
Main Methods:
- Comparative Genomic Hybridization (CGH) was performed on 38 established breast cancer cell lines.
- DNA copy number changes were analyzed and compared to published data from 698 uncultured tumors.
- Gene expression analysis using cDNA microarrays was conducted on four cell lines.
Main Results:
- Recurrent chromosomal gains (e.g., 8q, 1q, 20q) and losses (e.g., 8p, 18q, 1p) were identified.
- 35 recurrent high-level amplification sites were found, frequently involving 8q23, 20q13, and 3q25-q26.
- Significant overlap was observed between genetic alterations in cell lines and uncultured tumors.
- Overexpressed genes (RCH1, TOPO II, CAS, MYBL2) were identified at amplification hotspots.
Conclusions:
- CGH provides valuable DNA copy number profiles for breast cancer cell lines.
- These profiles closely resemble those of uncultured tumors, validating cell line models.
- The data facilitates the identification of genes involved in breast cancer through correlative analysis of copy number and gene expression.